Please assess the completion status of the following clinical trial:

Trial Title: Study to Assess the Efficacy and Safety of Dysport® in Cervical Dystonia

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE3
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* De novo patients with cervical dystonia~* Outpatient~* Patients to be of age 18 years or older~* Written informed consent to participate in the study~Exclusion Criteria:~* Pre-treatment of cervical dystonia with botulinum toxin~* Pre-treatment with botulinum toxin for any indication other than cervical dystonia within the past 12 months~* Pure retro- or antecollis~* Neurological or other diseases which may affect head and neck motor function or neuromuscular transmission, e.g. polyneuropathy with pareses, myasthenia, myopathy, motor neurone diseases, Bekhterev's disease

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- 1 (Type: EXPERIMENTAL): None

Based on this trial design, predict the completion outcome and termination type (if applicable).